Research assay kit BEK-2233
cellbiologicalELISA

research assay kit
research assay kit
Add to favorites
Compare this product
 

Characteristics

Applications
for research
Sample type
cell, biological
Analysis mode
ELISA

Description

The Eagle Bioscience’s Human LR3 IGF-I ELISA Assay Kit is intended for the quantitative determination of LR3IGF-I in cell culture supernatants. The Eagle Bioscience’s Human LR3 IGF-I ELISA Assay Kit is for research use only Sizes: 1 Plate Kit (12 x 8 wells), 2 Plate Kit (24 x 8 wells) Intended Use The Eagle Bioscience’s Human LR3 IGF-I ELISA Kit has been developed and validated to quantify LR3IGF-I protein in cell culture medium. It is primary use is to measure LR3IGF-I in media and during downstream processing of media following a production cycle and is not intended for other use. For research use only and not to be used for diagnostic procedures. Assay Background Human LR3 insulin-like Growth Factor-I (LR3IGF-I) is an 83 amino acid analogue of human IGF-I comprising the complete IGF-I sequence with the substitution of an Arginine for the Glutamine at position 3, plus a 13 amino acid extension peptide at the N-terminus. Human LR3IGF-I is more potent than IGF-I in vitro and in vivo. This increased potency is due to reduced binding of LR3IGF-I to most of the IGF binding proteins that modify the biological actions of IGF-I. Human LR3IGF-I binds to the type I IGF receptor with similar affinity to wild type IGF-I. LR3IGF-I was developed by GroPep Bioreagents specifically for supplementation of mammalian cell culture to support the survival and proliferation of cells. It is engineered to have a higher biological potency than native IGF-I or IGF-II and has several advantages over recombinant insulin.

Catalogs

No catalogs are available for this product.

See all of Eagle Biosciences‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.